EVOLENT HEALTH INC - A (EVH)

US30050B1017 - Common Stock

29.26  -0.87 (-2.89%)

After market: 29.26 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
908M
-1.80%		1.352B
48.90%		1.964B
45.26%		2.493B
26.94%
EBITDA
YoY % growth
17.64M
22.67%		70.8M
301.36%		136.212M
92.39%		255.18M
87.34%
EBIT
YoY % growth
-42.4M
9.98%		3.6M
108.49%		12.797M
255.47%		160.99M
1,158.03%
Operating Margin
-4.67%0.27%0.65%6.46%
EPS
YoY % growth
0.02
109.52%		0.91
4,450.00%		0.88
-3.30%		1.17
32.96%		N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		0.23
11.20%
Revenue
Q2Q % growth		606.28M
41.75%
EBITDA
Q2Q % growth		55.226M
EBIT
Q2Q % growth		32.609M
2,617.42%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.23
130.00%		0.150.0852.95%
Q3 2023
Q2Q % growth		 0.30
-49.15%		0.070.23333.18%
Q2 2023
Q2Q % growth		 0.14
40.00%		0.110.0322.82%
Q1 2023
Q2Q % growth		 0.21
75.00%		0.200.012.68%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 556.055M
45.41%		547.82M8.235M1.50%
Q3 2023
Q2Q % growth		 511M
44.92%		514.33M-3.33M-0.65%
Q2 2023
Q2Q % growth		 469.1M
46.64%		465.31M3.79M0.81%
Q1 2023
Q2Q % growth		 427.7M
43.96%		438.68M-10.98M-2.50%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.43% 5.09% -3.5% 9.42%
Revenue-0.1% 8.6% 0.44% 5.99%